Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Neural Regen Res ; 16(7): 1317-1322, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33318411

ABSTRACT

Müller cells (MC) are considered dormant retinal progenitor cells in mammals. Previous studies demonstrated ephrin-As act as negative regulators of neural progenitor cells in the retina and brain. It remains unclear whether the lack of ephrin-A2/A3 is sufficient to promote the neurogenic potential of MC. Here we investigated whether the MC is the primary retinal cell type expressing ephrin-A2/A3 and their role on the neurogenic potential of Müller cells. In this study, we showed that ephrin-A2/A3 and their receptor EphA4 were expressed in retina and especially enriched in MC. The level of ephrinAs/EphA4 expression increased as the retina matured that is correlated with the reduced proliferative and progenitor cell potential of MC. Next, we investigated the proliferation in primary MC cultures isolated from wild-type and A2-/- A3-/- mice by 5-ethynyl-2'-deoxyuridine (EdU) incorporation. We detected a significant increase of EdU+ cells in MC derived from A2-/- A3-/- mice. Next, we investigated the role of ephrin-A2/A3 in mice undergoing photoreceptor degeneration such as Rhodopsin knockout (Rho-/-) mice. To further evaluate the role of ephrin-A2/A3 in MC proliferation in vivo, EdU was injected intraperitoneally to adult wild-type, A2-/- A3-/- , Rho-/- and Rho-/- A2-/- A3-/- mice and the numbers of EdU+ cells distributed among different layers of the retina. EphrinAs/EphA4 expression was upregulated in the retina of Rho-/- mice compared to the wild-type mice. In addition, cultured MC derived from ephrin-A2-/- A3-/- mice also expressed higher levels of progenitor cell markers and exhibited higher proliferation potential than those from wild-type mice. Interestingly, we detected a significant increase of EdU+ cells in the retinas of adult ephrin-A2-/- A3-/- mice mainly in the inner nuclear layer; and these EdU+ cells were co-localized with MC marker, cellular retinaldehyde-binding protein, suggesting some proliferating cells are from MC. In Rhodopsin knockout mice (Rho-/- A2-/- A3-/- mice), a significantly greater amount of EdU+ cells were located in the ciliary body, retina and RPE than that of Rho-/- mice. Comparing between 6 and 12 weeks old Rho-/- A2-/- A3-/- mice, we recorded more EdU+ cells in the outer nuclear layer in the 12-week-old mice undergoing severe retinal degeneration. Taken together, Ephrin-A2/A3 are negative regulators of the proliferative and neurogenic potentials of MC. Absence of ephrin-A2/A3 promotes the migration of proliferating cells into the outer nuclear layer and may lead to retinal cell regeneration. All experimental procedures were approved by the Animal Care and Use Committee at Schepens Eye Research Institute, USA (approval No. S-353-0715) on October 24, 2012.

2.
Front Immunol ; 11: 585918, 2020.
Article in English | MEDLINE | ID: mdl-33281816

ABSTRACT

Retinal ischemia/reperfusion injury (RI) is a common cause of irreversible visual impairment and blindness in elderly and critical unmet medical need. While no effective treatment is available for RI, microglial activation and local immune responses in the retina are thought to play important roles in the pathophysiology of neurodegeneration. While survival and activation of microglia depend critically on colony-stimulating factor receptor (CSF-1R) signaling, it remains unclear if targeting the retinal immune microenvironments by CSF-1RAb after RI is sufficient to rescue vision and present a potentially effective therapy. Here we used rodent models of RI and showed that retinal ischemia induced by acute elevation of intraocular pressure triggered an early activation of microglia and macrophages in the retina within 12 h. This was followed by lymphocyte infiltration and increased production of pro-inflammatory cytokines. Intravitreal injection of CSF-1R neutralizing antibody (CSF-1RAb) after RI significantly blocked microglial activation and the subsequent T cell recruitment. This also led to improved retinal ganglion cell survival and function measured by cell quantification and electroretinogram positive scotopic threshold responses, as well as increased visual acuity and contrast sensitivity as assessed by optomotor reflex-based assays, when compared to the isotype-treated control group. Moreover, the administration of CSF-1RAb efficiently attenuated inflammatory responses and activation of human microglia in culture, suggesting a therapeutic target with human relevance. These results, together with the existing clinical safety profiles, support that CSF-1RAb may present a promising therapeutic avenue for RI, a currently untreatable condition, by targeting microglia and the immune microenvironment in the retina to facilitate neural survival and visual function recovery.


Subject(s)
Antibodies, Neutralizing/pharmacology , Microglia/drug effects , Microglia/immunology , Optic Neuropathy, Ischemic/immunology , Receptor, Macrophage Colony-Stimulating Factor/antagonists & inhibitors , Animals , Cellular Microenvironment/drug effects , Humans , Male , Mice , Mice, Inbred C57BL , Optic Neuropathy, Ischemic/pathology , Rats , Rats, Sprague-Dawley , Recovery of Function/drug effects , Retina
3.
Nat Commun ; 9(1): 3914, 2018 09 20.
Article in English | MEDLINE | ID: mdl-30237502

ABSTRACT

The originally published version of this Article contained an error in Figure 4. The bar chart in panel f was inadvertently replaced with a duplicate of the bar chart in panel e. This error has now corrected in both the PDF and HTML versions of the Article.

4.
Nat Commun ; 9(1): 3209, 2018 08 10.
Article in English | MEDLINE | ID: mdl-30097565

ABSTRACT

Glaucoma is the most prevalent neurodegenerative disease and a leading cause of blindness worldwide. The mechanisms causing glaucomatous neurodegeneration are not fully understood. Here we show, using mice deficient in T and/or B cells and adoptive cell transfer, that transient elevation of intraocular pressure (IOP) is sufficient to induce T-cell infiltration into the retina. This T-cell infiltration leads to a prolonged phase of retinal ganglion cell degeneration that persists after IOP returns to a normal level. Heat shock proteins (HSP) are identified as target antigens of T-cell responses in glaucomatous mice and human glaucoma patients. Furthermore, retina-infiltrating T cells cross-react with human and bacterial HSPs; mice raised in the absence of commensal microflora do not develop glaucomatous T-cell responses or the associated neurodegeneration. These results provide compelling evidence that glaucomatous neurodegeneration is mediated in part by T cells that are pre-sensitized by exposure to commensal microflora.


Subject(s)
Glaucoma/immunology , Microbiota , Nerve Degeneration/immunology , T-Lymphocytes/immunology , Animals , Axons/pathology , Female , Germ-Free Life , Glaucoma/complications , Glaucoma/pathology , Glaucoma/physiopathology , Heat-Shock Proteins/metabolism , Humans , Intraocular Pressure , Male , Mice, Inbred C57BL , Nerve Degeneration/complications , Nerve Degeneration/pathology , Nerve Degeneration/physiopathology , Retinal Ganglion Cells/pathology
5.
Curr Eye Res ; 42(1): 134-144, 2017 01.
Article in English | MEDLINE | ID: mdl-27259952

ABSTRACT

PURPOSE: The development of a suitable storage method for retinal pigment epithelium (RPE) is necessary in the establishment of future RPE replacement therapy, and storage temperature has proven to be pivotal for cell survival. ARPE-19, a widely used model for RPE, has been shown to yield the greatest number of viable cells when stored at 16°C compared to other storage temperatures. In this study, we analyze the gene expression profile of cultured ARPE-19 cells after seven days of storage at different temperatures in an effort to predict the gene-level consequences of storage of RPE transplants. MATERIALS AND METHODS: ARPE-19 cells were cultured until confluence and then stored in minimum essential medium at 4°C, 16°C, and 37°C for seven days. The total RNA was isolated and the gene expression profile was determined using DNA microarrays. The Results were validated using qPCR. RESULTS: Principal component and hierarchical clustering analyses show that the gene expression profiles of cell cultures stored at different temperatures cluster into separate groups. Cultures stored at 4°C cluster closest to the control cultures that were not stored and display the least change in gene expression after storage (157 differentially expressed genes). Cultures stored at 16°C and 37°C display a much larger change in differential gene expression (1787 and 1357 differentially expressed genes, respectively). At 16°C, the expression of several genes with proposed tumor suppressor functions was markedly increased. Changes in regulation of several known signaling pathways and of oxidative stress markers were discovered at both 16°C and 37°C, and activation of the angiogenesis marker vascular endothelial growth factor (VEGF) was discovered at 37°C. There was no evidence of the activation of inflammatory processes in stored cell cultures. CONCLUSION: ARPE-19 cultures stored at 16°C show the greatest propensity to modulate their gene expression profile in a manner that supports cell survival during storage.


Subject(s)
Cryopreservation , Gene Expression Regulation/physiology , Organ Preservation , Retinal Pigment Epithelium/cytology , Signal Transduction/genetics , Transcriptome/genetics , Cell Survival/genetics , Cells, Cultured , Gene Expression Profiling , Humans , Oligonucleotide Array Sequence Analysis , Oxidative Stress/genetics , RNA/isolation & purification , Real-Time Polymerase Chain Reaction , Retinal Pigment Epithelium/metabolism
6.
Am J Pathol ; 186(11): 2783-2797, 2016 11.
Article in English | MEDLINE | ID: mdl-27643530

ABSTRACT

Evolving research has provided evidence that noninvasive electrical stimulation (ES) of the eye may be a promising therapy for either preserving or restoring vision in several retinal and optic nerve diseases. In this review, we focus on minimally invasive strategies for the delivery of ES and accordingly summarize the current literature on transcorneal, transorbital, and transpalpebral ES in both animal experiments and clinical studies. Various mechanisms are believed to underlie the effects of ES, including increased production of neurotrophic agents, improved chorioretinal blood circulation, and inhibition of proinflammatory cytokines. Different animal models have demonstrated favorable effects of ES on both the retina and the optic nerve. Promising effects of ES have also been demonstrated in clinical studies; however, all current studies have a lack of randomization and/or a control group (sham). There is thus a pressing need for a deeper understanding of the underlying mechanisms that govern clinical success and optimization of stimulation parameters in animal studies. In addition, such research should be followed by large, prospective, clinical studies to explore the full potential of ES. Through this review, we aim to provide insight to guide future research on ES as a potential therapy for improving vision.


Subject(s)
Electric Stimulation Therapy , Optic Nerve Diseases/therapy , Retinal Diseases/therapy , Vision, Ocular/physiology , Animals , Cats , Disease Models, Animal , Humans , Optic Nerve/physiopathology , Rabbits , Rats , Research , Retina/physiopathology
7.
Proc Natl Acad Sci U S A ; 109(13): 4768-73, 2012 Mar 27.
Article in English | MEDLINE | ID: mdl-22411830

ABSTRACT

Chondroitin sulfate proteoglycans (CSPGs) represent a major barrier to regenerating axons in the central nervous system (CNS), but the structural diversity of their polysaccharides has hampered efforts to dissect the structure-activity relationships underlying their physiological activity. By taking advantage of our ability to chemically synthesize specific oligosaccharides, we demonstrate that a sugar epitope on CSPGs, chondroitin sulfate-E (CS-E), potently inhibits axon growth. Removal of the CS-E motif significantly attenuates the inhibitory activity of CSPGs on axon growth. Furthermore, CS-E functions as a protein recognition element to engage receptors including the transmembrane protein tyrosine phosphatase PTPσ, thereby triggering downstream pathways that inhibit axon growth. Finally, masking the CS-E motif using a CS-E-specific antibody reversed the inhibitory activity of CSPGs and stimulated axon regeneration in vivo. These results demonstrate that a specific sugar epitope within chondroitin sulfate polysaccharides can direct important physiological processes and provide new therapeutic strategies to regenerate axons after CNS injury.


Subject(s)
Axons/pathology , Axons/physiology , Chondroitin Sulfate Proteoglycans/immunology , Epitopes/immunology , Nerve Regeneration/physiology , Animals , Antibodies, Blocking/pharmacology , Antibodies, Monoclonal/pharmacology , Antibodies, Neutralizing/pharmacology , Axons/drug effects , Carbohydrate Conformation , Chickens , Chondroitin Sulfate Proteoglycans/chemistry , Chondroitin Sulfates/chemistry , Chondroitin Sulfates/immunology , Ganglia, Spinal/drug effects , Ganglia, Spinal/metabolism , Growth Cones/drug effects , Growth Cones/metabolism , Growth Cones/pathology , Mice , Neurites/enzymology , Receptor-Like Protein Tyrosine Phosphatases, Class 2/metabolism , Signal Transduction/drug effects
8.
Am J Pathol ; 179(6): 2788-97, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21967817

ABSTRACT

Neuroglobin (NGB), a newly discovered member of the globin superfamily, may regulate neuronal survival under hypoxia or oxidative stress. Although NGB is greatly expressed in retinal neurons, the biological functions of NGB in retinal diseases remain largely unknown. We investigated the role of NGB in an experimental model of glaucoma, a neurodegenerative disorder that usually involves elevation of intraocular pressure (IOP). Elevated IOP is thought to induce oxidative stress in retinal ganglion cells (RGCs), thereby causing RGC death and, eventually, blindness. We found that NGB plays a critical role in increasing RGC resistance to ocular hypertension and glaucomatous damage. Elevation of IOP stimulated a transient up-regulation of endogenous NGB in RGCs. Constitutive overexpression of NGB in transgenic mice prevented RGC damage induced by glutamate cytotoxicity in vitro and/or by chronic IOP elevation in vivo. Moreover, overexpression of NGB attenuated ocular hypertension-induced superoxide production and the associated decrease in ATP levels in mice, suggesting that NGB acts as an endogenous neuroprotectant to reduce oxidative stress and improve mitochondrial function, thereby promoting RGC survival. Thus, NGB may modulate RGC susceptibility to glaucomatous neural damage. Manipulating the expression and bioactivity of NGB may represent a novel therapeutic strategy for glaucoma.


Subject(s)
Glaucoma/physiopathology , Globins/physiology , Intraocular Pressure/physiology , Nerve Tissue Proteins/physiology , Retinal Ganglion Cells/physiology , Animals , Cells, Cultured , Glaucoma/metabolism , Globins/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Mitochondrial Diseases/metabolism , Mitochondrial Diseases/physiopathology , Nerve Tissue Proteins/metabolism , Neuroglobin , Oxidative Stress , Reactive Oxygen Species/metabolism , Superoxides/metabolism
9.
Invest Ophthalmol Vis Sci ; 52(1): 36-44, 2011 Jan 05.
Article in English | MEDLINE | ID: mdl-20702815

ABSTRACT

PURPOSE: To characterize a glaucoma model of mice, the authors adopted and modified a method of inducing the chronic elevation of intraocular pressure (IOP) by anterior chamber injection of polystyrene microbeads. METHODS: Chronic elevation of IOP was induced unilaterally in adult C57BL/6J mice by injecting polystyrene microbeads to the anterior chamber. Effectiveness of microbeads of different sizes (small, 10 µm; large, 15 µm) on inducing IOP elevation was compared, and IOP was measured every other day using a tonometer. After maintaining elevated IOP for 2, 4, or 8 weeks, the degree of RGC and axon degeneration was assessed quantitatively using electron microscopy, fluorogold, retrograde labeling, and immunohistochemistry. RESULTS: Eighty-one of 87 mice that received anterior chamber injection of microbeads exhibited consistent IOP elevation above that of control eyes. Injection of small microbeads induced longer and higher peak value of IOP elevation compared with that of the large microbeads. A single injection of small microbeads resulted in a 4-week elevation of IOP that was maintained to an 8-week period after a second injection of microbeads in week 4. As the duration of IOP elevation increased, RGC bodies and their axons degenerated progressively and reached an approximately 50% loss after an 8-week elevation of IOP. CONCLUSIONS: Anterior chamber injection of microbeads effectively induced IOP elevation and glaucomatous optic neuropathy in mice. Development of an inducible mouse model of elevated IOP will allow applications of mouse genetic technology to the investigation of the mechanisms and the evaluation of treatment strategies of glaucoma.


Subject(s)
Disease Models, Animal , Intraocular Pressure , Microspheres , Ocular Hypertension/etiology , Optic Nerve Diseases/etiology , Animals , Anterior Chamber , Axons/metabolism , Axons/ultrastructure , Injections , Mice , Mice, Inbred C57BL , Microscopy, Fluorescence , Ocular Hypertension/metabolism , Ocular Hypertension/pathology , Optic Nerve Diseases/metabolism , Optic Nerve Diseases/pathology , Polystyrenes , Retinal Ganglion Cells/metabolism , Retinal Ganglion Cells/ultrastructure , Time Factors , Tonometry, Ocular , Tubulin/metabolism
10.
Arch Ophthalmol ; 127(11): 1475-80, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19901213

ABSTRACT

OBJECTIVE: To determine whether systemic minocycline can protect photoreceptors in experimental retinal detachment (RD). METHODS: Retinal detachment was induced in mice by subretinal injection of sodium hyaluronate, 1.4%. In 1 experiment, mice received daily injections of minocycline (group 1) or saline (group 2). In a second experiment, mice were treated with minocycline or saline beginning 24 hours prior, immediately after, or 24 hours after experimental RD. In both experiments, photoreceptor cell survival and apoptosis were assessed by immunohistochemistry with primary antibodies against photoreceptor cell markers, rod rhodopsin, and cone opsin, and by terminal deoxynucleotidyl transferase-mediated dUTP-biotin end labeling. RESULTS: Photoreceptor cell apoptosis was detected at day 1 after experimental RD, with apoptotic cells peaking in number at day 3 and dropping by day 7. Treatment with minocycline significantly reduced the number of apoptotic photoreceptor cells associated with RD when given 24 hours before or even 24 hours after RD. CONCLUSIONS: Our data suggest that minocycline may be useful in the treatment of photoreceptor degeneration associated with RD, even when given up to 24 hours after RD. CLINICAL RELEVANCE: Use of minocycline in patients with macula-off RD may prevent photoreceptor apoptosis and glial cell proliferation, improving final visual outcomes.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Minocycline/therapeutic use , Photoreceptor Cells, Vertebrate/drug effects , Retinal Degeneration/prevention & control , Animals , Apoptosis/drug effects , Caspase 3/metabolism , Cell Survival , Disease Models, Animal , Fluorescent Antibody Technique, Indirect , Glial Fibrillary Acidic Protein/metabolism , In Situ Nick-End Labeling , Mice , Mice, Inbred C57BL , Monocytes/pathology , Opsins/metabolism , Photoreceptor Cells, Vertebrate/metabolism , Photoreceptor Cells, Vertebrate/pathology , Retinal Degeneration/diagnosis , Retinal Degeneration/metabolism , Retinal Detachment , Rhodopsin/metabolism
11.
Invest Ophthalmol Vis Sci ; 49(3): 1142-50, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18326742

ABSTRACT

PURPOSE: Retinal Müller glia in higher vertebrates have been reported to possess progenitor cell properties and the ability to generate new neurons after injury. This study was conducted to determine the signals that can activate this dormant capacity of Müller glia in adult mice, by studying their behavior during glutamate stimulation. METHODS: Various concentrations of glutamate and its analogue alpha-aminoadipate, which specifically binds Müller glia, were injected subretinally in adult mice. Proliferating retinal cells were labeled by subretinal injection of 5'-bromo-2'-deoxyuridine (BrdU) followed by immunohistochemistry. Müller cell fates were analyzed in retinal sections by using double immunolabeling with primary antibodies against Müller and other retina-specific cell markers. The effects of glutamate and alpha-aminoadipate were also determined in purified Müller cell cultures. RESULTS: Although high levels of glutamate induce retinal damage, subtoxic levels of glutamate directly stimulate Müller glia to re-enter the cell cycle and induce neurogenesis in vivo and in purified Müller cell cultures. alpha-Aminoadipate, which selectively target glial cells, also induced expression of progenitor cell markers by Müller cells in vitro or stimulated Müller cell migration to the outer nuclear layer (ONL) and to differentiate into photoreceptors in vivo. CONCLUSIONS: Mature Müller glia in adult mice can be induced to dedifferentiate, migrate, and generate new retinal neurons and photoreceptor cells by alpha-aminoadipate or glutamate signaling. The results of this study suggest a novel potential strategy for treating retinal neurodegeneration, including retinitis pigmentosa and age-related macular degeneration, without transplanting exogenous cells.


Subject(s)
2-Aminoadipic Acid/pharmacology , Cell Differentiation/drug effects , Excitatory Amino Acid Antagonists/pharmacology , Neuroglia/cytology , Retina/cytology , Stem Cells/cytology , Animals , Bromodeoxyuridine/metabolism , Carrier Proteins/metabolism , Cell Cycle/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Fluorescent Antibody Technique, Indirect , Glutamic Acid/pharmacology , Mice , Mice, Inbred C57BL , Neuroglia/metabolism , Recoverin/metabolism , Stem Cells/metabolism
12.
Invest Ophthalmol Vis Sci ; 48(6): 2760-8, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17525210

ABSTRACT

PURPOSE: To characterize the reactions of retinal glial cells (astrocytes and Müller cells) to retinal injury in mice that lack glial fibrillary acidic protein (GFAP) and vimentin (GFAP-/-Vim-/-) and to determine the role of glial cells in retinal detachment (RD)-induced photoreceptor degeneration. METHODS: RD was induced by subretinal injection of sodium hyaluronate in adult wild-type (WT) and GFAP-/-Vim-/- mice. Astroglial reaction and subsequent monocyte recruitment were quantified by measuring extracellular signal-regulated kinase (Erk) and c-fos activation and the level of expression of chemokine monocyte chemoattractant protein (MCP)-1 and by counting monocytes/microglia in the detached retinas. Immunohistochemistry, immunoblotting, real-time quantitative polymerase chain reaction (PCR), and enzyme-linked immunosorbent assay (ELISA) were used. RD-induced photoreceptor degeneration was assessed by terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) and measurement of outer nuclear layer (ONL) thickness. RESULTS: RD-induced reactive gliosis, characterized by GFAP and vimentin upregulation, Erk and c-fos activation, MCP-1 induction, and increased monocyte recruitment in WT mice. Absence of GFAP and vimentin effectively attenuated reactive responses of retinal glial cells and monocyte infiltration. As a result, detached retinas of GFAP-/-Vim-/- mice exhibited significantly reduced numbers of TUNEL-positive photoreceptor cells and increased ONL thickness compared with those of WT mice. CONCLUSIONS: The absence of GFAP and vimentin attenuates RD-induced reactive gliosis and, subsequently, limits photoreceptor degeneration. Results of this study indicate that reactive retinal glial cells contribute critically to retinal damage induced by RD and provide a new avenue for limiting photoreceptor degeneration associated with RD and other retinal diseases or damage.


Subject(s)
Glial Fibrillary Acidic Protein/physiology , Neuroglia/physiology , Retina/pathology , Retinal Degeneration/prevention & control , Retinal Detachment/complications , Vimentin/physiology , Animals , Blotting, Western , Chemokine CCL2/metabolism , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Extracellular Signal-Regulated MAP Kinases/metabolism , Fluorescent Antibody Technique, Indirect , Glial Fibrillary Acidic Protein/deficiency , Gliosis/etiology , Gliosis/metabolism , Gliosis/prevention & control , In Situ Nick-End Labeling , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Microglia/physiology , Monocytes/physiology , Photoreceptor Cells, Vertebrate/pathology , Proto-Oncogene Proteins c-fos/metabolism , Retinal Degeneration/etiology , Retinal Degeneration/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Vimentin/deficiency
13.
Mol Vis ; 12: 867-78, 2006 Aug 07.
Article in English | MEDLINE | ID: mdl-16917487

ABSTRACT

PURPOSE: Photoreceptor apoptosis is associated with retinal detachment (RD) induced photoreceptor degeneration. Previously, we demonstrated the importance of caspase activation for RD-induced photoreceptor death in a rat model of RD. However, extracellular signals that precede the activation of caspases and photoreceptor degeneration remain unclear. The aim of this study is to characterize the molecular and cellular responses that occur after RD. The expression of cytokines, chemokines, and growth factors were examined in a rat model of RD. METHODS: RD was induced in adult rats by subretinal injection of sodium hyaluronate. Retinal tissues were collected at various times (1, 3, 6, 24, and 72 h) after the induction of detachment. To screen for expressional changes in response to RD, major candidates for cytokines, chemokines, and growth factors were broadly examined by quantitative real time polymerase chain reaction (QPCR). To identify the cellular sources of the expressed genes, cells from various layers of the retina were obtained using laser capture microdissection (LCM), and their mRNAs were isolated. Protein expression was quantified by immunohistochemistry and Enzyme Linked-Immuno-Sorbent Assay (ELISA). To assess the potential of early response genes after RD to induce photoreceptor degeneration, exogenous recombinant proteins were subretinally injected and the photoreceptor cell death was assessed using a TdT-dUTP terminal nick-end labeling (TUNEL) assay at 24 h after RD. RESULTS: At 72 h after RD a significant increase in mRNA levels for tumor necrosis factor alpha (TNF-alpha), interleukin-1beta (IL-1beta), monocyte chemotactic protein-1 (MCP-1), and basic fibroblast growth factor (bFGF) were detected in the neural retina. LCM revealed increased expression of mRNA for bFGF and MCP-1 in all retinal layers, though bFGF was especially evident in the outer nuclear layer (ONL) and MCP-1 in the inner nuclear layer (INL). TNF-alpha was increased in the ONL and the INL, and IL-1beta was increased in the ganglion cell layer. Time course experiments showed that TNF-alpha, IL-1beta and MCP-1 increased within 1 h after RD, while bFGF was increased by 24 h. Increased protein expression for TNF-alpha, IL-1beta, and MCP-1 was demonstrated by ELISA at 6 h after RD. Immunohistochemistry showed TNF-alpha and bFGF expression in the whole retina, with IL-1beta specifically expressed in astrocytes and MCP-1 in Müller cells. Subretinal administration of MCP-1 significantly increased TUNEL-positive cells in the ONL 24 h after RD, while injection of vehicle control, TNF-alpha, or IL-1beta showed no effect. CONCLUSIONS: Retinal glial cells, including astrocytes and Müller cells, are a major source of cytokine induction after RD. The increased expression and release of MCP-1 may be an important cause of photoreceptor degeneration associated with RD. This study helps to understand the mechanisms of RD-induced photoreceptor degeneration. Our results may provide new therapeutic targets to prevent photoreceptor degeneration following RD.


Subject(s)
Chemokine CCL2/metabolism , Fibroblast Growth Factor 2/metabolism , Interleukin-1/metabolism , Retinal Detachment/metabolism , Tumor Necrosis Factor-alpha/metabolism , Animals , Apoptosis , Astrocytes/metabolism , Chemokine CCL2/genetics , Enzyme-Linked Immunosorbent Assay , Fibroblast Growth Factor 2/genetics , Immunohistochemistry , Interleukin-1/genetics , Male , Neuroglia/metabolism , Photoreceptor Cells, Vertebrate , RNA, Messenger/metabolism , Rats , Rats, Inbred BN , Retina/metabolism , Retina/pathology , Retinal Detachment/pathology , Retinal Ganglion Cells/metabolism , Tissue Distribution , Tumor Necrosis Factor-alpha/genetics
14.
Invest Ophthalmol Vis Sci ; 45(2): 648-54, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14744910

ABSTRACT

PURPOSE: To characterize photoreceptor cell apoptosis and cell loss in a mouse model of experimental retinal detachment (RD), and to use the technology of mouse genetics to study the molecular mechanisms underlying RD-associated photoreceptor degeneration. METHODS: Retinal detachments were created in adult wild-type and Bax-deficient mice by subretinal injection of 1.4% sodium hyaluronate. At 1, 3, 7, and 28 days after injection, animals were killed, eyes enucleated, and retinal sections studied by histochemistry, immunofluorescence labeling, and confocal microscopy. Rods and cones were labeled, and apoptotic cells were identified with terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL). Photoreceptor cell apoptosis and cell loss were assessed quantitatively by counting both surviving and TUNEL-positive rods and cones. RESULTS: TUNEL-positive cells were found within the outer nuclear layer (ONL) of the detached portions of the retina. They were detected in the detached retina on day 1, peaked on day 3, and dropped precipitously after day 7 after RD. Photoreceptor cell loss of both rods and cones followed a similar time course after RD. Moreover, deletion of the proapoptotic gene Bax in a knockout mouse model abolished the RD-associated photoreceptor cell degeneration. CONCLUSIONS: Apoptosis is a major mechanism leading to photoreceptor cell death after RD. Blockage of the activity of the proapoptotic molecule Bax in a knockout mouse model prevents photoreceptor cell apoptosis and cell loss. These data suggest that the Bax-mediated apoptotic signaling pathway plays a critical role in RD-associated photoreceptor cell death.


Subject(s)
Apoptosis , Photoreceptor Cells, Vertebrate/pathology , Proto-Oncogene Proteins c-bcl-2 , Proto-Oncogene Proteins/physiology , Retinal Degeneration/prevention & control , Retinal Detachment/prevention & control , Animals , Cell Survival , Disease Models, Animal , Fluorescent Antibody Technique, Indirect , In Situ Nick-End Labeling , Mice , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Confocal , Proto-Oncogene Proteins/deficiency , Proto-Oncogene Proteins/genetics , Retinal Degeneration/etiology , Retinal Degeneration/pathology , Retinal Detachment/complications , Retinal Detachment/pathology , bcl-2-Associated X Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...